We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Sales Growth Makes These 5 Stocks Good Bets Amid Coronavirus Woes
Read MoreHide Full Article
In challenging times like these, it’s not an easy task to find stocks that are expected to witness earnings growth in the near term. Therefore, one way to pick stocks is based on steady sales growth.
Sales growth is an important metric for any company, as it constitutes vital part of growth projections and is instrumental in strategic decision making. By monitoring this key metric over multiple time periods, one can clearly understand a company’s growth trend.
When companies incur losses, although temporarily, they are valued based on their revenues. Top-line growth (or decline) is usually an indicator of a company’s future earnings performance. While price to earnings and price to book value ratios can turn negative and cease to be relevant, the price-to-sales ratio is available even for firms that have hit choppy waters.
A company can improve earnings by resorting to cost-control measures, while maintaining stable revenues. However, superior profits can be achieved through steady revenue growth.
Huge sales numbers do not necessarily convert into profits. Hence, considering a company’s cash position, in addition to sales numbers, can prove to be more prudent. Substantial cash in hand and a steady cash flow lend a company more flexibility with respect to business decisions and investments.
Selecting Winning Stocks
In order to shortlist stocks that have witnessed impressive sales growth and a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow more than $500 million as our main screening parameters.
But sales growth and cash strength are not the absolute criteria for selecting stocks. Hence, we have added certain other factors to arrive at a winning strategy.
P/S Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.
% Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Estimate revisions, better than the industry, are often seen to trigger an increase in stock price.
Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs — an optimal situation.
Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means that the company is spending wisely and is in all likelihood profitable.
Here are five of the 16 stocks that qualified the screening:
Regency Centers Corporation (REG - Free Report) , based in Jacksonville, FL, is the preeminent national owner, operator, and developer of shopping centers. Its expected sales growth rate for fiscal 2020 is 2.5%. The stock currently carries a Zacks Rank #2.
Based in San Diego, CA, ResMed Inc. (RMD - Free Report) develops, manufactures, distributes, and markets medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders. Its expected sales growth rate for fiscal 2020 is 11.5%. The stock carries a Zacks Rank #2 at present.
Mountain View, CA-based Synopsys, Inc. (SNPS - Free Report) provides electronic design automation software products. The company’s expected sales growth rate for fiscal 2020 is 7.4% and it currently carries a Zacks Rank #2.
Cboe Global Markets, Inc. (CBOE - Free Report) , headquartered in Chicago, IL, operates as an options exchange. Its expected sales growth rate for 2020 is 10.6% and the stock carries a Zacks Rank #2 at present.
The Southern Company (SO - Free Report) is engaged in the generation, transmission, and distribution of electricity. This Atlanta, GA-based company’s sales are expected to increase 3.3% in 2020. The stock carries a Zacks Rank #2, currently.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
Sales Growth Makes These 5 Stocks Good Bets Amid Coronavirus Woes
In challenging times like these, it’s not an easy task to find stocks that are expected to witness earnings growth in the near term. Therefore, one way to pick stocks is based on steady sales growth.
Sales growth is an important metric for any company, as it constitutes vital part of growth projections and is instrumental in strategic decision making. By monitoring this key metric over multiple time periods, one can clearly understand a company’s growth trend.
When companies incur losses, although temporarily, they are valued based on their revenues. Top-line growth (or decline) is usually an indicator of a company’s future earnings performance. While price to earnings and price to book value ratios can turn negative and cease to be relevant, the price-to-sales ratio is available even for firms that have hit choppy waters.
A company can improve earnings by resorting to cost-control measures, while maintaining stable revenues. However, superior profits can be achieved through steady revenue growth.
Huge sales numbers do not necessarily convert into profits. Hence, considering a company’s cash position, in addition to sales numbers, can prove to be more prudent. Substantial cash in hand and a steady cash flow lend a company more flexibility with respect to business decisions and investments.
Selecting Winning Stocks
In order to shortlist stocks that have witnessed impressive sales growth and a high cash balance, we have selected 5-Year Historical Sales Growth (%) greater than X-Industry and Cash Flow more than $500 million as our main screening parameters.
But sales growth and cash strength are not the absolute criteria for selecting stocks. Hence, we have added certain other factors to arrive at a winning strategy.
P/S Ratio less than X-Industry: This metric determines the value placed on each dollar of a company’s revenues. The lower the ratio, the better it is for picking a stock since the investor is paying less for each unit of sales.
% Change F1 Sales Estimate Revisions (four weeks) greater than X-Industry: Estimate revisions, better than the industry, are often seen to trigger an increase in stock price.
Operating Margin (average last five years) greater than 5%: Operating margin measures how much every dollar of a company's sales translates into profits. A high ratio indicates that the company has good cost control and sales are increasing faster than costs — an optimal situation.
Return on Equity (ROE) greater than 5%: This metric will ensure that sales growth is translated into profits and the company is not hoarding cash. A high ROE means that the company is spending wisely and is in all likelihood profitable.
Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment. You can see the complete list of today’s Zacks #1 Rank stocks here.
Here are five of the 16 stocks that qualified the screening:
Regency Centers Corporation (REG - Free Report) , based in Jacksonville, FL, is the preeminent national owner, operator, and developer of shopping centers. Its expected sales growth rate for fiscal 2020 is 2.5%. The stock currently carries a Zacks Rank #2.
Based in San Diego, CA, ResMed Inc. (RMD - Free Report) develops, manufactures, distributes, and markets medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders. Its expected sales growth rate for fiscal 2020 is 11.5%. The stock carries a Zacks Rank #2 at present.
Mountain View, CA-based Synopsys, Inc. (SNPS - Free Report) provides electronic design automation software products. The company’s expected sales growth rate for fiscal 2020 is 7.4% and it currently carries a Zacks Rank #2.
Cboe Global Markets, Inc. (CBOE - Free Report) , headquartered in Chicago, IL, operates as an options exchange. Its expected sales growth rate for 2020 is 10.6% and the stock carries a Zacks Rank #2 at present.
The Southern Company (SO - Free Report) is engaged in the generation, transmission, and distribution of electricity. This Atlanta, GA-based company’s sales are expected to increase 3.3% in 2020. The stock carries a Zacks Rank #2, currently.
Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and backtesting software.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance